# LEXURE for Post-Stroke Aphasia

Study · id `cardio:ct-nct07570264` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07570264](<https://clinicaltrials.gov/study/NCT07570264>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07570264

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 116 participants.

## Technical summary

Registry record NCT07570264. Randomized; single masking; primary purpose treatment. Start 2026-04-16 (actual); primary completion 2026-12-30 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 116 participants (planned count; ClinicalTrials.gov record NCT07570264, source copy `cardio:ctgov-nct07570264-2026-05-14`, retrieved 2026-10-26)
- Started: 2026-04-16 (actual) (ClinicalTrials.gov record NCT07570264, source copy `cardio:ctgov-nct07570264-2026-05-14`, retrieved 2026-10-26)
- Primary completion: 2026-12-30 (anticipated) (ClinicalTrials.gov record NCT07570264, source copy `cardio:ctgov-nct07570264-2026-05-14`, retrieved 2026-10-26)
- Completion: 2026-12-30 (anticipated) (ClinicalTrials.gov record NCT07570264, source copy `cardio:ctgov-nct07570264-2026-05-14`, retrieved 2026-10-26)
- Countries: South Korea (ClinicalTrials.gov record NCT07570264, source copy `cardio:ctgov-nct07570264-2026-05-14`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07570264-2026-05-14`, retrieved 2026-10-26)

## The registry's words

- Brief title: LEXURE for Post-Stroke Aphasia
- Condition: Aphasia
- Intervention (Device): LEXURE
- Intervention (Behavioral): Workbook
- Lead sponsor: Nunaps Inc
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Stroke (`core:stroke`)

## Provenance

Content hash: 9d594d705f82c35974878c2aaabe4ec769c9acce88f602abeaf13334861531ef
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
